Healthcare Leaders Income ETF

Healthcare Leaders Income ETF

Healthcare Leaders ETF
Date Symbol NAV ($) NAV Change ($) MKT ($) MKT Change ($) Distribution Total ($)

Fund Quick Facts February 28, 2017

Cusip HHL 42227H101
Cusip HHL.U 42227H200
Total AUM $167.9 million
Management Fee 0.85%
Total Holdings 23
Income Distribution Monthly
Recent Distribution $0.0583
Distribution Method Cash
RSP Eligible Yes

Top Ten Holdings

As of February 28, 2017

Security Portfolio (%)
Bristol-Myers Squibb Company 5.1
UnitedHealth Group Inc. 5.1
Gilead Sciences, Inc. 5.1
Celgene Corporation 5.0
Johnson & Johnson 5.0
Pfizer Inc. 5.0
Boston Scientific Corp. 4.9
Quest Diagnostics Inc. 4.9
Stryker Corporation 4.9
Medtronic PLC 4.9

Fund Overview

The Fund invests in an equally-weighted portfolio of equity securities of 20 Healthcare Issuers from the Healthcare Leaders Investable Universe that have a minimum market capitalization of US$5 billion at the time of investment and have options in respect of their Equity Securities listed on a recognized options exchange. The portfolio is rebalanced semi-annually back to equal weights.

The Fund’s investment objectives are to provide Unitholders with: (i) the opportunity for capital appreciation; (ii) monthly cash distributions; and (iii) lower overall volatility of Portfolio returns than would otherwise be experienced by owning Equity Securities of the Healthcare Leaders directly.

In order to seek to generate additional returns, the Investment Manager will sell call options each month on Equity Securities held in the Portfolio.

The Fund’s distribution target is $0.0583 per Class A Unit per month ($0.70 per annum) or US$0.0583 per Class U Unit per month (US$0.70 per annum).

Cumulative Growth $10,000 Invested

December 31, 2016 (NAV pricing)



Link to prospectus Why Invest

Link to prospectus Quarterly Summary

Link to prospectus Prospectus Eng | Fr

Link to prospectus Prospectus Amendment No. 1 Eng | Fr

Link to prospectus Prospectus Amendment No. 2 EngFr

Link to prospectus Summary Documents  HHL EngFr

Link to prospectus Summary Documents  HHL.U Eng | Fr

Portfolio Management

Paul MacDonald Harvest Portfolios Group Inc.


Chief Investment Officer


Portfolio Manager


Portfolio Manager

Investor Suitability

Investors seeking a regular income through investment in the worlds leading healthcare companies.

Investors seeking to hold their investment for medium to long term.



Historical Prices



Historical Distributions



Portfolio Holdings

Healthcare Leaders Income ETF
Quarterly Portfolio Holdings
as of December 31, 2016

Security % of Portfolio
Zoetis Inc. Class A 5.5
Eli Lilly and Company 5.4
UnitedHealth Group Inc. 5.3
Quest Diagnostics Inc. 5.3
Bristol-Myers Squibb Company 5.2
Agilent Technologies, Inc. 5.2
AbbVie Inc. 5.2
Pfizer Inc. 5.1
Novartis AG ADR 5.1
Boston Scientific Corp. 5.0
Johnson & Johnson 5.0
GlaxoSmithKline PLC ADR 4.9
Becton, Dickinson and Company 4.8
Gilead Sciences, Inc. 4.8
Merck & Co., Inc. 4.7
Amgen Inc. 4.7
Allergan PLC 4.7
Medtronic PLC 4.3
Teva Pharmaceutical Industries Ltd. 4.3
McKesson Corporation 4.2
Cash and other assets and liabilities 1.8
Foreign Currency Forward 0.0
Options (0.3)

Press Releases


Healthcare Leaders Income ETF

The Fund originally commenced operations as a TSX listed closed-end fund on December 18, 2014 and converted into an exchange-traded fund on October 24, 2016.  Commissions, management fees and expenses all may be associated with investing in HARVEST Exchange Traded Funds. Please read the relevant prospectus before investing. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account income taxes payable by any securityholder that would have reduced returns. The funds are not guaranteed, their values change frequently and past performance may not be repeated. 100% of distributions are received in cash. If the Fund earns less than the amounts distributed, the difference is a return of capital. Tax, investment and all other decisions should be made with guidance from a qualified professional.